Share and Follow
The Sydney Local Health District (SLHD) is currently investigating a series of Aspergillus infections that have emerged within the transplant unit of a hospital. These cases occurred between October and December, prompting heightened scrutiny.
SLHD has suggested a potential connection between this fungal outbreak and the hospital’s ongoing $940 million redevelopment project. Construction work on this large-scale renovation commenced in 2023 and is believed to possibly contribute to the issue.
Aspergillus, a type of mold, thrives in soil, dust, and moist environments, particularly in areas undergoing significant construction or demolition activities.
Infections can lead to severe health problems, including difficulty breathing, coughing up blood, and even respiratory failure.
Out of the six confirmed cases of infection, two patients have unfortunately passed away, while the remaining four have suffered serious illness.
A spokesperson from SLHD said people inhale the aspergillus spores every day without becoming unwell, however it can have a more harmful impact on immunocompromised people.
This includes patients undergoing organ transplant procedures.
“SLHD extends its deepest condolences to the families of the patients who died at Royal Prince Alfred Hospital and acknowledges the impact on all patients and families,” the spokesperson said.
“Even before the full extent of the cluster was known, multiple actions were undertaken as quickly as possible beginning with an investigation by infectious diseases clinicians.”
It added that “fungal infections are a known risk for patients who are significantly immunocompromised, including patients undergoing organ transplant procedures”.
The ward was closed while an investigation took place, with transplant patients relocated and potentially at-risk patients contacted.
“Additional patient safety measures were implemented, including a deep clean of the transplant ward, review of air intake points, upgrades to air filtration systems and comprehensive air quality testing,” the spokesperson added.
NEVER MISS A STORY: Get your breaking news and exclusive stories first by following us across all platforms.